Media Coverage

Medical technology company Proteomics International Laboratories Ltd (Proteomics International; ASX:...

Proteomics International Laboratories announced today that it has signed an agreement to evaluate it...

Medical technology company Proteomics International (ASX: PIQ) has teamed up with biotech stock Dime...

Proteomics International announces it has joined forces with the Busselton Population Medical Resear...

Proteomics International is pleased to announce the official product launch of PromarkerD, its world...

Proteomics International is pleased to announce the appointment of a new Board member along with eng...

Proteomics International has awarded its inaugural Industrial Scholarship to Imogen Sorby.

See article

Proteomics International is pleased to announce its participation in the Accelerating Australia cons...

Proteomics International is pleased to announce that its balance sheet has been boosted by the recei...

Article: New biomarkers may accurately identify renal disease in patients with type 2 diabetes

Proteomics International announces the publication of a clinical research paper about its flagship d...

Proteomics International is pleased to announce that the United States patent for its PromarkerD dia...

Article: Dr Boreham’s Crucible: Proteomics International Laboratories

Positive results for PromarkerD

Proteomics International, a leader in providing predictive diagnostics and biosimilars analytical se...

Proteomics International Laboratories says clinical validation study confirms PromarkerD performance

Proteomics International Laboratories Clinical Validation Study Confirms PromarkerD Performance

Clinical validation results confirm PromarkerD can predict diabetic kidney disease better than any c...

Clinical validation results confirm PromarkerD can predict diabetic kidney disease better than any c...

Clinical Validation Study confirms PromarkerD can predict Diabetic KidneyDisease better than any Cur...

Proteomics International announced today results from its validation clinical study showing that the...

Proteomics International is proud to announce the extension of our world leading accreditation and l...

MedTech company Proteomics International is pleased to advise that Independent Investment Research (...

Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, presents...

Proteomics International Laboratories targets first commercial sales for PromarkerD in 2017

Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Dia...

Proteomics International is the leader in predictive diagnostics for diabetic kidney disease accordi...

PromarkerD Predictive Diagnostics For DKD To Roll-out In Asia

PromarkerD Predictive Diagnostics For DKD To Rollout In Asia

PromarkerD糖尿病肾脏疾病预测试验在亚洲推出

PromarkerD Predictive Diagnostics For DKD To Roll-out In Asia

Proteomics International, the leader in predictive diagnostics for diabetic kidney disease, will adv...

PromarkerD Predictive Diagnostics For DKD To Rollout In Asia

Proteomics-International-Laboratories-to-bring-PromarkerD-to-Asia

PromarkerD Predictive Diagnostics For DKD To Roll-out In Asia

Proteomics International announces the publication today of the data underpinning its PromarkerD dia...